Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 3159-07-7 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 3159-07-7

    Manufacturers/Suppliers

    MARKET PLACE

    PharmaCompass
    CAS 3159-07-7
    Also known as: 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepine, 3159-07-7, 5h-benzo[b][1,4]benzothiazepin-6-one, Dibenzo[b,f][1,4]thiazepine-11-[10h]one, Dibenzothiazepinone, Nsc653252
    Molecular Formula
    C13H9NOS
    Molecular Weight
    227.28  g/mol
    InChI Key
    RTERDTBXBYNZIS-UHFFFAOYSA-N
    FDA UNII
    FL6FG1E3WF
    1 2D Structure

    CAS 3159-07-7

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5H-benzo[b][1,4]benzothiazepin-6-one
    2.1.2 InChI
    InChI=1S/C13H9NOS/c15-13-9-5-1-3-7-11(9)16-12-8-4-2-6-10(12)14-13/h1-8H,(H,14,15)
    2.1.3 InChI Key
    RTERDTBXBYNZIS-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1=CC=C2C(=C1)C(=O)NC3=CC=CC=C3S2
    2.2 Other Identifiers
    2.2.1 UNII
    FL6FG1E3WF
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepine

    2. 3159-07-7

    3. 5h-benzo[b][1,4]benzothiazepin-6-one

    4. Dibenzo[b,f][1,4]thiazepine-11-[10h]one

    5. Dibenzothiazepinone

    6. Nsc653252

    7. Fl6fg1e3wf

    8. Gnf-pf-769

    9. 10h-dibenzo[b,f][1,4]thiazepin-11-one

    10. Mfcd00901197

    11. Nsc-653252

    12. Dibenzo(b,f)(1,4)thiazepin-11(10h)-one

    13. Dibenzo[b,f][1,4]thiazepine-11(10-h)-one

    14. Dibenzo[b,f][1,4]thiazepine-11-(10h)one

    15. Dibenzo[b,f][1,4]thiazepinone

    16. 10,11-dihydro-11-oxodibenz[b,f][1,4]thiazepine

    17. Dibenzo(b,f)(1,4)thiazepine-11(10-h)-one

    18. 10,11-dihydro-11-oxodibenz(b,f)(1,4)thiazepine

    19. 10,11-dihydro-11-oxodibenzo(b,f)(1,4)thiazepine

    20. Quetiapine Impurity G

    21. Quetiapine Impurtiy G

    22. Dibenzo[b,4]thiazepinone

    23. Unii-fl6fg1e3wf

    24. Dibenzothiazepinone [usp]

    25. Schembl8988

    26. Mls000698398

    27. Quetiapine Related Compound G

    28. Chembl598054

    29. Zinc14023

    30. Dtxsid10953553

    31. Hms2666m13

    32. {dibenzo[b,f][1,4]thiazepinone}

    33. Bcp30999

    34. Cs-m2280

    35. Quetiapine Fumarate Impurity G [ep]

    36. Quetiapine Related Compound G [usp]

    37. Dibenzo[b,f][1,4]thiazepin-11-ol

    38. Akos005216133

    39. Ac-5341

    40. Dibenzo-[b,f][1,4]thiazepin-11-one

    41. Ds-0806

    42. Fs-3018

    43. Sb67310

    44. Dibenzo-[b,f] [1,4]thiazepin-11-one

    45. Dibenzothiazepinone [usp Impurity]

    46. Smr000224931

    47. Sy047017

    48. 10h-dibenzo[b,f][1,4]thiazepine-11-one

    49. Db-005658

    50. Dibenz[b,f][1,4]thiazepin-11(10h)-one

    51. Am20040155

    52. D3693

    53. Dibenzo[b,f][1,4]thiazepine-11(10-h)one

    54. Ft-0600897

    55. Di-benzo[b,f ][1,4]thiazepin-11(10h)-one

    56. Dibenzo[b,f][1,4]thiazepin-11(10h)-one #

    57. O10365

    58. Quetiapine Related Compound G [usp-rs]

    59. 5,6-dihydro-6-oxodibenzo(b,f)-1,4-thiazepine

    60. Dibenzo [b-f] [1-4]thiazepine 11-[10h]one

    61. 159d077

    62. Ae-641/30103015

    63. 10,11-dihydro-11-oxodibenz[b,f] [1,4]thiazepine

    64. 10,11-dihydrodibenzo[b,f][1,4] Thiazepin-11-one

    65. 10,11-dihydrodibenzo[b,f][1,4]thiazepin-11-one

    66. Q-200955

    67. Quetiapine Fumarate Impurity G [ep Impurity]

    68. Quetiapine Related Compound G [usp Impurity]

    69. 1-(2,3-dimethyl-1h-indol-6-yl)-n,n-dimethylmethanamine

    70. Quetiapine Impurtiy G (dibenzo[b,f][1,4]thiazepine-11(10-h)-one)

    71. 2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one

    72. 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepine Pound>>dibenzo[b,f][1,4]thiazepin-11(10h)-one

    2.4 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 227.28 g/mol
    Molecular Formula C13H9NOS
    XLogP32.9
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count0
    Exact Mass227.04048508 g/mol
    Monoisotopic Mass227.04048508 g/mol
    Topological Polar Surface Area54.4 Ų
    Heavy Atom Count16
    Formal Charge0
    Complexity281
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Cangzhou Senary Chemical Science-te...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      4- (4-aminophenyl)morpholin-3-one

      PDF Supplier PDF
      URL Supplier Web Content
      438056-69-0
      Rivaroxaban
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Cangzhou Senary Chemical Science-te...

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        (S)-(+)-N-(2,3-epoxypropyl)phthalimide

        PDF Supplier PDF
        URL Supplier Web Content
        161596-47-0
        Rivaroxaban
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        Cangzhou Senary Chemical Science-te...

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          5- chlorothiophene-2-carboxylic acid

          PDF Supplier PDF
          URL Supplier Web Content
          24065-33-6
          Rivaroxaban
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          Ask Us for Pharmaceutical Supplier and Partner
          Ask Us, Find A Supplier / Partner
          No Commissions, No Strings Attached, Get Connected for FREE

          What are you looking for?

          How can we help you?

          The request can't be empty

          Please read our Privacy Policy carefully

          You must agree to the privacy policy

          The name can't be empty
          The company can't be empty.
          The email can't be empty Please enter a valid email.
          The mobile can't be empty
          minakem-m-2024-05-27

          Access Virtual Booth

          Contact Supplier

          View Presentation

          Bora Pharmaceuticals- Making success more certain.

          Access Virtual Booth

          Contact Supplier

          View Presentation

          Post Enquiry
          POST ENQUIRY

          Market Place

          Market Place

          PharmaCompass

          Home

          Market Place

          Menu

          Post Enquiry

          Post Enquiry

          Market Place

          Market Place

          Search